Latest Insider Transactions at Predictive Oncology Inc. (POAI)
This section provides a real-time view of insider transactions for Predictive Oncology Inc. (POAI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Predictive Oncology Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Predictive Oncology Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 01
2021
|
Charles Lee Sr Nuzum Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,887
+33.62%
|
-
|
|
Apr 01
2021
|
Clair Gregory Sr St. Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,887
+37.28%
|
-
|
|
Apr 01
2021
|
Richard L Gabriel Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,959
+22.55%
|
-
|
|
Apr 01
2021
|
J Melville Engle |
BUY
Grant, award, or other acquisition
|
Direct |
4,959
+35.45%
|
-
|
|
Apr 01
2021
|
Daniel E Handley Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,959
+35.45%
|
-
|
|
Apr 01
2021
|
Nancy Chung Welch Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,959
+33.93%
|
-
|
|
Feb 24
2021
|
Carl I. Schwartz Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
100,401
+5.54%
|
$100,401
$1.43 P/Share
|
|
Oct 22
2020
|
Carl I. Schwartz Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
640
-0.04%
|
$0
$0.85 P/Share
|